AI assistant
Sending…
Processa Pharmaceuticals, Inc. — Director's Dealing 2025
Sep 18, 2025
35172_dirs_2025-09-18_d3f60a8a-bb13-4c21-9d93-83166e2ac975.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-07-24
Reporting Person: Yorke Justin W (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3737 | Direct |
| Common Stock | 12400 | Indirect |
| Common Stock | 31232 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $0.65 | 2030-01-29 | Common Stock (12400) | 12400 | Indirect |
| Warrants | $0.65 | 2030-01-29 | Common Stock (6200) | 6200 | Indirect |
More from Processa Pharmaceuticals, Inc.
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Jan 7
Regulatory Filings
2025
Dec 15
Major Shareholding Notification
2025
Nov 7
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Oct 15